The Effect of HIIT, MICT in Patients With Myocardial Infarction
Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Apr 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different types of exercise programs, High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT), can help patients who have recently had a heart attack, also known as a myocardial infarction. The study will last for 12 weeks and aims to see how these workouts affect overall heart health, including improvements in fitness levels, heart function, body fat, and even mental well-being.
To participate, you need to be between 18 and 75 years old and have had a heart attack within the last 6 weeks to 3 months. You should also have undergone a procedure to improve blood flow to your heart and be willing to commit to the rehabilitation program. Participants will undergo fitness tests and will be monitored throughout the study. It's important to note that individuals with certain serious health conditions or who are already doing high-intensity exercise may not be eligible. This trial is a great opportunity for eligible patients to take an active step in their recovery while contributing to important research on heart health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18 -75 years
- • 2. Acute myocardial infarction (AMI) patients between 6 weeks and 3 months and had been underwent revascularization, and New York Heart Association functional classification (NYHA) Class I-III; (AMI confirmed by the World Health Organization definition (presence of symptoms of ischemia and changes in electrocardiogram) or the Third Universal Definition of Myocardial Infarction (elevation of a cardiac biomarker along with presence of either symptoms of myocardial infarction or changes in electrocardiogram))
- • 3. Willing and able to attend the complete cardiac rehabilitation(CR)program on their own,assigned the Informed consent form.
- • 4. Complete the cardiopulmonary exercise testing (CPET) at enrollment or has the CPET report within 1 month.
- Exclusion Criteria:
- • 1. High-intensity exercise frequently
- • 2. Currently participating in any other clinical trials
- • 3. Have any other diseases which limit their life to less than a year (e.g. severe valvular disease, recurrent ventricular arrhythmias, NYHA Class IV heart failure, severe aortic incompetence, severe atrial fibrillation, cancers, and end-stage renal or liver disease)
- • 4. Dementia ; disability or sports contraindication
- • 5. Severe acute liver failure
- • 6. Severe acute renal failure
- • 7. Unstable vital signs
- • 8. Site investigators consider that the patient will be unable to complete the study and/or attend for follow-up.
About Guangdong Provincial People's Hospital
Guangdong Provincial People's Hospital is a leading tertiary healthcare institution located in Guangdong Province, China, renowned for its comprehensive medical services and advanced research capabilities. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical science through innovative research and the rigorous evaluation of new therapies and interventions. With a multidisciplinary team of experienced clinicians and researchers, the institution prioritizes patient safety and ethical standards while fostering collaborations with academic and industry partners to enhance healthcare outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Qingshan Geng
Study Chair
Guangdong Provincial People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials